Asia Healthcare Holdings takes majority stake in Asian Institute of Nephrology and Urology
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
Subscribe To Our Newsletter & Stay Updated